Skip to search formSkip to main contentSkip to account menu

NSC 139105

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

triazinate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1985
Highly Cited
1985
Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
A human T-lymphoblast cell line, CCRF-CEM/R1, resistant to methotrexate by virtue of increased dihydrofolate reductase activity… 
1980
1980
Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injections.
The tissue distribution of BAF was compared by intravenous and subcutaneous injections in rats bearing Walker 256 carcinoma… 
1979
1979
Penetration of Baker's antifolate (NSC 139105) & 3-deazauridine (NSC 126849) into the central nervous system of man
1978
1978
Stereochemistry of dihydrofolate reductase inhibitor antitumor agents: molecular structure of "Baker's antifol" (NSC 139105, triazinate) and "insoluble Baker's antifol" (NSC 113423).
1977
1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma
Triazinate (Baker's Antifol, NSC 139105) was given to 28 patients as a single agent in the chemotherapy of advanced colerectal… 
1975
1975
Liver disease and clinical pharmacology of Baker's antifolate (BAF, NSC 139105)
1973
1973
Pre-clinical trials of a new triazine antifolate, nsc 139105. Abstr.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)